Syngenta: Management announcement
BASEL, Switzerland, Oct. 22, 2012 /PRNewswire/ — Syngenta today announced that Sandro Aruffo, Head of R&D, will take medical leave. During his absence, Robert Berendes, Head of Business Development, will assume ad interim leadership of the R&D function in addition to his existing responsibilities.
Syngenta is one of the world’s leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions.Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements.We refer you to Syngenta’s publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties.Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.
Syngenta International AG Media contact: Analyst/Investor contact: Media Office Paul Barrett Jennifer Gough CH-4002 Basel Switzerland +41 61 323 0597 Switzerland +41 61 323 5059 Switzerland USA +1 202 737 6521 Tel: +41 61 323 2323 Fax: +41 61 323 2424 www.syngenta.com